Navigation Links
5- and 10-year survival continues to improve for US children with hematologic malignancies
Date:9/9/2008

5- and 10-year survival rates continue to improve for children under the age of 15 who are diagnosed with acute lymphoblastic leukemia (ALL), acute non-lymphoblastic leukemia, or non-Hodgkin lymphoma (NHL) in the United States, researchers report in the September 9 online issue of the Journal of the National Cancer Institute.

Advances in treatment for childhood hematologic malignancies have led to increased long-term survival in these patients. However, most population-based studies include survival data from patients who were diagnosed in the mid-1990s or before and, therefore, may not reflect current outcomes.

To improve on those data, Hermann Brenner, M.D., of the German Cancer Research Center in Heidelberg and colleagues used period analysis to assess current trends. The method has been validated in adult cancers and accurately reflects long-term outcomes but has not been used in pediatric cancers. Using period analysis, the researchers compared 5- and 10-year survival estimates for patients included in the 1990-1994, 1995-41999, and 2000-2004 periods. They also developed methods to predict survival in patients diagnosed in 2005-2009.

Between 1990-1994 and 2000-2004, 5- and 10-year survival increased from 80.2 percent to 87.5 percent and from 73.4 percent to 83.8 percent, respectively, for patients with ALL; from 41.9 percent to 59.9 percent and from 38.7 percent to 59.1 percent, respectively, for patients with acute non-lymphoblastic leukemia; and from 76.6 percent to 87.7 percent and from 73.0 percent to 86.9 percent, respectively, for patients with NHL. The 5- and 10-year survival rates for the 1990჻� period were 96.1 percent and 94.4 percent, respectively, for patients with Hodgkin lymphoma and did not substantially change over the study period. The estimated 10-year survival for patients diagnosed in 2005჻� with ALL was 88.0 percent, with acute non-lymphoblastic leukemia was 63.9 percent, with NHL was 90.6 percent, and with Hodgkin lymphoma was 94.3 percent.

"Our period analysis revealed that survival after diagnosis with childhood hematologic malignancies has improved greatly over the past decade," the authors conclude. "Improvements in survival in childhood hematologic malignancies are most likely attributable to changes in how these diseases are treated."

In an accompanying editorial, Alan Wayne, M.D., of the National Cancer Institute in Bethesda, Md., and colleagues review the progress that has been made in improving survival in children diagnosed with a hematologic malignancy. They note, however, that intensifying existing therapies is unlikely to bring further gains and incorporation of molecularly targeted therapies will be essential for continued progress.

With that in mind, the period analysis used by Brenner and colleagues, including their projections for future benefits, could speed drug development. "If their projections prove to be valid, this approach may facilitate earlier evaluation of molecularly targeted agents and more rapid advances in therapy," the editorialists write.


'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. National Domestic Violence Hotline Unveils 10-Year Blueprint to Significantly Reduce Domestic Violence in America
2. Almost Half of 10-Year-Olds Have Tasted Alcohol
3. Childrens Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision
4. Sonic Innovations Celebrates 10-Year Anniversary
5. Sonic Innovations Launches Two New Hearing Aid Products in Conjunction With Companys 10-Year Anniversary
6. ClearWay Minnesota(SM) Celebrates 10-Year Anniversary of Settlement
7. Stereotaxis Magnetic Navigation System Used to Successfully Treat an Inoperable Congenital Heart Defect in a 10-Year Old Patient
8. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
9. Survival differences by race most apparent in advanced stages of breast cancer
10. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
11. Human C-reactive protein regulates myeloma tumor cell growth and survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving compilation of ... value to God. “Letters From Home” is the creation of published author, John Allred, ... Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on four continents. ...
(Date:9/21/2017)... ... September 21, 2017 , ... With ProSlideshow Portrait from Pixel Film Studios creating ... can select from up to two layers of subject matter along with fully customizable ... within Final Cut Pro X. , With ProSlideshow Portrait each user are ...
(Date:9/21/2017)... ... 21, 2017 , ... The American Addiction Treatment Association (AATA) ... in the addiction treatment industry entitled: Special Investigations Unit (SIU) – What ... state and federal governments are increasingly scrutinizing the addiction treatment industry for fraudulent ...
(Date:9/21/2017)... Ca (PRWEB) , ... September 21, 2017 , ... Bill ... services to its customers, and give back to the community. For over 37 years, ... the most successful companies serving plumbing in San Diego. They were chosen ...
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. ... screening tests, has received two prestigious recognitions that acknowledge the promise of its ... Preora has been named a Top 100 Finalist for the 16th annual ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology: